(Q46931957)

English

Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases

scientific article published in December 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17960603

Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17960603

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

Huamin Wang

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17960603

author name string

Dario Ribero

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17960603

Matteo Donadon

3

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17960603

Daria Zorzi

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17960603

Melanie B Thomas

5

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17960603

Cathy Eng

6

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17960603

David Z Chang

7

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17960603

Steven A Curley

8

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17960603

Eddie K Abdalla

9

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17960603

Lee M Ellis

10

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17960603

Jean-Nicolas Vauthey

11

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17960603

language of work or name

0 references

publication date

1 December 2007

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17960603

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17960603

110

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17960603

12

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17960603

2761-2767

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17960603

Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

21 January 2018

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

21 January 2018

Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

21 January 2018

Oxaliplatin toxicity masquerading as recurrent colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

21 January 2018

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

21 January 2018

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

21 January 2018

Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

21 January 2018

Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

21 January 2018

Complete response of colorectal liver metastases after chemotherapy: does it mean cure?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

21 January 2018

Cystic changes in hepatic and peritoneal metastases from gastrointestinal stromal tumors treated with Gleevec

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

21 January 2018

Pathologic, radiologic and PET scan response of gastrointestinal stromal tumors after neoadjuvant treatment with imatinib mesylate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

21 January 2018

SENECIO DISEASE, OR CIRRHOSIS OF THE LIVER DUE TO SENECIO POISONING

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

21 January 2018

Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

21 January 2018

Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

21 January 2018

Downstaging or downsizing: time for a new staging system in advanced colorectal cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

7 January 2021

based on heuristic

inferred from DOI database lookup

The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

7 January 2021

based on heuristic

inferred from DOI database lookup

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

7 January 2021

based on heuristic

inferred from DOI database lookup

Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

7 January 2021

based on heuristic

inferred from DOI database lookup

Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23099

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.23099

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17960603

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17960603

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46931957&oldid=2138479452"